Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Military Products Will Get US FDA Fast-Track Review

Executive Summary

FDA and the US Department of Defense launched a program to prioritize development of medical products for use in the battlefield. The program implements recently enacted compromise legislation that resolved a turf battle between the two agencies.

Advertisement

Related Content

‘State Of HHS’ Speech Highlights Price Transparency, Disaster Response
First Concussion Blood Test Leverages De Novo, Breakthrough Pathways
FDA Authorizes Emergency Use Of Devices In War Time, Bill Signed By The President Clarifies
Battlefield Emergency Use Bill Faces Pushback From US FDA, Authorizing Committees

Topics

Advertisement
UsernamePublicRestriction

Register

MT122058

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel